Pulsed Electric Field Focal Ablation Catheter From Galaxy Medical and Japan Life Will Seek FDA Clearance
Companies create U.S. distribution agreement
May 12, 2021 Galaxy Medical and Japan Lifeline announced an exclusive distribution agreement for the Alpha1 ablation catheter in the United States, developed by Japan Lifeline for use with the Galaxy Centauri Pulsed Electric Field (PEF) System. Under the terms of the agreement, Galaxy will pursue U.S. regulatory approval for Alpha1 in support of eventual commercialization of the CENTAURI PEF System.
PEF is a new type of ablation technology for use in electrophysiology (EP) procedures. It is also called electroporation, because the field it creates opens pores in the cell walls, leading to cell death. The goal is deliver more controlled lesions with less collateral damage.